Cabot Stock Price, News & Analysis (NYSE:CBT)

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cabot in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CBT shares.
View CBT analyst ratings or view top-rated stocks.

4 Wall Street analysts have issued 1 year price objectives for Cabot's shares. Their CBT share price targets range from $70.00 to $103.00. On average, they expect the company's share price to reach $83.60 in the next year. This suggests a possible upside of 10.4% from the stock's current price.
View analysts price targets for CBT or view top-rated stocks among Wall Street analysts.

Cabot's stock was trading at $66.84 at the start of the year. Since then, CBT shares have increased by 13.3% and is now trading at $75.71.
View the best growth stocks for 2023 here.

Cabot saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 1,270,000 shares, an increase of 30.6% from the October 31st total of 972,100 shares. Based on an average daily volume of 269,100 shares, the days-to-cover ratio is currently 4.7 days. Currently, 2.3% of the shares of the stock are sold short.
View Cabot's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 8th 2024.
View our CBT earnings forecast.

Cabot Co. (NYSE:CBT) released its quarterly earnings data on Monday, November, 6th. The specialty chemicals company reported $1.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.47 by $0.18. The specialty chemicals company earned $965 million during the quarter, compared to the consensus estimate of $991.48 million. Cabot had a net margin of 11.32% and a trailing twelve-month return on equity of 24.65%. The business's quarterly revenue was down 13.2% compared to the same quarter last year. During the same quarter last year, the business posted $1.55 earnings per share.

Cabot declared a quarterly dividend on Friday, November 10th. Investors of record on Friday, November 24th will be given a dividend of $0.40 per share on Friday, December 8th. This represents a $1.60 dividend on an annualized basis and a yield of 2.11%. The ex-dividend date of this dividend is Wednesday, November 22nd.
Read our dividend analysis for CBT.

Cabot (NYSE:CBT) pays an annual dividend of $1.60 per share and currently has a dividend yield of 2.06%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 20.65%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CBT will have a dividend payout ratio of 22.22% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CBT.

ETFs with the largest weight of Cabot (NYSE:CBT) stock in their portfolio include Invesco Dorsey Wright Basic Materials Momentum ETF (PYZ).Global X Autonomous & Electric Vehicles ETF (DRIV).

Cabot issued an update on its FY24 earnings guidance on Monday, November, 6th. The company provided earnings per share guidance of $6.30-6.80 for the period, compared to the consensus estimate of $6.54.

40 employees have rated Cabot Chief Executive Officer Sean Keohane on Glassdoor.com. Sean Keohane has an approval rating of 96% among the company's employees. This puts Sean Keohane in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cabot investors own include Pfizer (PFE), Broadcom (AVGO), Energy Transfer (ET), AT&T (T), Gilead Sciences (GILD), Intel (INTC), NVIDIA (NVDA), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and Coca-Cola (KO).

Cabot's stock is owned by a number of retail and institutional investors. Top institutional investors include FMR LLC (5.84%), Earnest Partners LLC (5.66%), Fuller & Thaler Asset Management Inc. (3.70%), Northern Trust Corp (1.33%), Charles Schwab Investment Management Inc. (1.20%) and Bank of New York Mellon Corp (1.14%). Insiders that own company stock include Hobart Kalkstein, Karen A Kalita, Karen A Kalita and Sean D Keohane.
View institutional ownership trends.

Shares of CBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.